These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 24526623)

  • 1. Alzheimer's disease and type 2 diabetes: multiple mechanisms contribute to interactions.
    Jayaraman A; Pike CJ
    Curr Diab Rep; 2014 Apr; 14(4):476. PubMed ID: 24526623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting soluble tumor necrosis factor as a potential intervention to lower risk for late-onset Alzheimer's disease associated with obesity, metabolic syndrome, and type 2 diabetes.
    De Sousa Rodrigues ME; Houser MC; Walker DI; Jones DP; Chang J; Barnum CJ; Tansey MG
    Alzheimers Res Ther; 2019 Dec; 12(1):1. PubMed ID: 31892368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes.
    Peterson RG; Jackson CV; Zimmerman K; de Winter W; Huebert N; Hansen MK
    J Diabetes Res; 2015; 2015():487816. PubMed ID: 25961053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.
    Grizzanti J; Lee HG; Camins A; Pallas M; Casadesus G
    Nutr Res; 2016 Dec; 36(12):1305-1315. PubMed ID: 27923524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-sugar diets, type 2 diabetes and Alzheimer's disease.
    Moreira PI
    Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):440-5. PubMed ID: 23657152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on potential links between type 2 diabetes mellitus and Alzheimer's disease.
    De Sousa RAL; Harmer AR; Freitas DA; Mendonça VA; Lacerda ACR; Leite HR
    Mol Biol Rep; 2020 Aug; 47(8):6347-6356. PubMed ID: 32740795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is metabolic syndrome X an inflammatory condition?
    Das UN
    Exp Biol Med (Maywood); 2002 Dec; 227(11):989-97. PubMed ID: 12486208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1.
    Knight EM; Ruiz HH; Kim SH; Harte JC; Hsieh W; Glabe C; Klein WL; Attie AD; Buettner C; Ehrlich ME; Gandy S
    Acta Neuropathol Commun; 2016 Feb; 4():16. PubMed ID: 26916443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research.
    Bello-Chavolla OY; Antonio-Villa NE; Vargas-Vázquez A; Ávila-Funes JA; Aguilar-Salinas CA
    Curr Diabetes Rev; 2019; 15(6):456-470. PubMed ID: 30648514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?
    Biessels GJ; Kappelle LJ;
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1041-4. PubMed ID: 16246041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert EA; Nestel PJ; Esler MD; Dixon JB; Chopra R; Tilbrook AJ; Schlaich MP; Lambert GW
    Diabetes; 2012 Oct; 61(10):2506-16. PubMed ID: 22664956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
    Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
    Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links.
    Ribe EM; Lovestone S
    J Intern Med; 2016 Nov; 280(5):430-442. PubMed ID: 27739227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies.
    Rizvi AA; Stoian AP; Rizzo M
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration.
    Duarte AI; Candeias E; Correia SC; Santos RX; Carvalho C; Cardoso S; Plácido A; Santos MS; Oliveira CR; Moreira PI
    Biochim Biophys Acta; 2013 Apr; 1832(4):527-41. PubMed ID: 23314196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin: an emerging treatment for Alzheimer's disease dementia?
    Morris JK; Burns JM
    Curr Neurol Neurosci Rep; 2012 Oct; 12(5):520-7. PubMed ID: 22791280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics of Alzheimer's disease and aging.
    Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
    Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers.
    Nasoohi S; Parveen K; Ishrat T
    J Alzheimers Dis; 2018; 66(3):857-885. PubMed ID: 30372683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: A Focus on Insulin Resistance.
    Ezkurdia A; Ramírez MJ; Solas M
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.